ZAI LAB LTD0000006 - Asset Resilience Ratio

Latest as of March 2026: 0.91%

ZAI LAB LTD0000006 (1ZLB) has an Asset Resilience Ratio of 0.91% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of ZAI LAB LTD0000006 to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€10.00 Million

≈ $11.69 Million USD Cash + Short-term Investments

Total Assets

€1.10 Billion

≈ $1.28 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how ZAI LAB LTD0000006's Asset Resilience Ratio has changed over time. See net asset quality index of ZAI LAB LTD0000006 to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down ZAI LAB LTD0000006's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of ZAI LAB LTD0000006.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€10.00 Million	0.91%
Total Liquid Assets	€10.00 Million	0.91%

Asset Resilience Insights

Limited Liquidity: ZAI LAB LTD0000006 maintains only 0.91% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

ZAI LAB LTD0000006 Industry Peers by Asset Resilience Ratio

Compare ZAI LAB LTD0000006's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for ZAI LAB LTD0000006 (2021–2025)

The table below shows the annual Asset Resilience Ratio data for ZAI LAB LTD0000006.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.85%	€10.00 Million ≈ $11.69 Million	€1.17 Billion ≈ $1.37 Billion	-26.98pp
2024-12-31	27.83%	€330.00 Million ≈ $385.80 Million	€1.19 Billion ≈ $1.39 Billion	+26.26pp
2023-12-31	1.57%	€16.30 Million ≈ $19.06 Million	€1.04 Billion ≈ $1.21 Billion	--
2022-12-31	0.00%	€0.00 ≈ $0.00	€1.22 Billion ≈ $1.43 Billion	--
2021-12-31	27.64%	€445.00 Million ≈ $520.25 Million	€1.61 Billion ≈ $1.88 Billion	--

pp = percentage points

About ZAI LAB LTD0000006

F:1ZLB Germany Biotechnology

Market Cap

$2.05 Billion

€1.75 Billion EUR

Market Cap Rank

#6638 Global

#964 in Germany

Share Price

€1.56

Change (1 day)

+5.41%

52-Week Range

€1.36 - €3.52

All Time High

€152.00